In this context, the blockage of the IFN-α/β receptor with monoclonal antibodies prevents diabetes in nonobese diabetic mice (10, 11), and the inhibition of IFN-α intracellular signaling prevents the major histocompatibility complex (MHC) I overexpression in a model of β-cells (12). The gene discussed is IFNA2; the disease is diabetes mellitus.